What is the study about?
TRAILBLAZER-ALZ 5 New clinical trial to slow down the progression of Alzheimer's Dementia. Donanemab has been recently been on the BBC news and come to SABP to look at the safety and side efficacy of the medication.
Who can take part?
Recruitment has now finished.